Post PCI bleeding can cause kidney injury

Original title: Impact of Periprocedural Bleeding on Incidente of Constrast-Induced Acute Kidney Injury in patients treated with Percutaneous Coronary Intervention. Reference: Yohei Ohno, et al. J Am Coll Cardiol 2013;62:1260-6

Contrast induced acute kidney injury (CI-AKI) is a serious complication associated to higher morbimortality rates and higher costs, but its correlation to bleeding remains controversial. This study included 2646 patients undergoing PCI; 315 (12%) presented CI AKI. 

Patients were divided in 5 groups according to hemoglobin variation after PCI (Hb): Group A showed no change in Hb levels (290 patients), B: a decrease in Hb 3 g/dl (244 patients). There were no differences in baseline characteristics between the groups.

Kidney injury was associated to cardiac insufficiency CF III or IV, infarction with ST segment elevation, as well as a greater decrease in HB levels (odds ratio 2.23, IC 95% 1.37 to 3.63 p=0.001). CI-AKI patients presented higher rates of mortality compared to stable patients, as well as a composite of heart failure, cardiogenic shock, death, major bleeding and need of transfusion.

There was a significative correlation between HB level decrease and the events rate that, globally, resulted in 12%. Each group separately showed different rates:  A 6%, B 8%, C 11%, D 17% y E 26% (p<0.001). Minor bleeding did not have significant impact.

Conclusion:

Periprocedural bleeding was significantly associated with CI-AKI, with CI-AKI incidence correlating with bleeding severity. These patients presented high risk of in-hospital mortality.

Comment:

It is known that kidney injury is a marker of bad evolution. This analysis also shows that bleeding may cause kidney injury after PCI and, in addition, it marks a bad evolution. It is important to remember the transradial approach reduces major bleeding events and, hence, should be the first choice not only for PC interventions but also for catheterizations.

Courtesy of Dr Carlos Fava,
Interventional cardiologist
Favaloro Foundation
Buenos Aires – Argentina 

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long-Term Predictors of Valve Deterioration After TAVI

Transcatheter aortic valve implantation (TAVI) has become an innovative technology for the treatment of patients with severe aortic valve stenosis. Initially implemented in elderly...

Coronary access after TAVI with fourth- and fifth-generation Evolut valves: the EPROMPT-CA study

The expansion of transcatheter aortic valve implantation (TAVI) toward younger and lower-risk patients has increased the relevance of post-procedural coronary access. In this context,...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...